Anesth Pain Med.  2021 Jul;16(3):225-231. 10.17085/apm.21063.

Possible roles of platelets in liver transplantation: regeneration and cancer recurrence

• Han S

• KMID: 2519051
• DOI: http://doi.org/10.17085/apm.21063

Abstract

When tissue injury results to breakage, platelets are not only involved in plug formation and wound sealing, but they also play an important role throughout the tissue recovery process. Specifically, platelets accumulate at the site of injury and release a large number of biologically active mediators at injury sites, which initiate or modulate damaged tissue regeneration. Moreover, extensive experimental evidence has elucidated the involvement of platelets in tumor growth and metastasis. As such, this mini-review aimed to highlight the relatively lesser known functions of platelets.

Keyword

Hepatocellular carcinoma; Liver regeneration; Living donors; Metastasis; Recurrence; Transfusion-related acute lung injury

Reference

1. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science. 2010; 328:562–4.

2. Tesfamariam B. Involvement of platelets in tumor cell metastasis. Pharmacology & Therapeutics. 2016; 157:112–9.

3. Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011; 11:123–34.

4. Stellos K, Kopf S, Paul A, Marquardt JU, Gawaz M, Huard J, et al. Platelets in regeneration. Semin Thromb Hemost. 2010; 36:175–84.

5. Gawaz M, Vogel S. Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. Blood. 2013; 122:2550–4.

6. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997; 276:60–6.

7. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004; 5:836–47.

8. Meyer J, Balaphas A, Fontana P, Sadoul K, Morel P, Gonelle-Gispert C, et al. Platelets in liver regeneration. ISBT Sci Ser. 2017; 12:455–62.

9. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, et al. Platelet-derived serotonin mediates liver regeneration. Science. 2006; 312:104–7.

10. Clavien PA. Liver regeneration: a spotlight on the novel role of platelets and serotonin. Swiss Med Wkly. 2008; 138:361–70.

11. Stolz DB, Mars WM, Petersen BE, Kim TH, Michalopoulos GK. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res. 1999; 59:3954–60.

12. Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology. 2001; 34(4 Pt 1):688–93.

13. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007; 356:1545–59.

14. Han S, Park HW, Song JH, Gwak MS, Lee WJ, Kim G, et al. Association between intraoperative platelet transfusion and early graft regeneration in living donor liver transplantation. Ann Surg. 2016; 264:1065–72.

15. Han S, Ko JS, Gwak MS, Kim GS. Association of platelet count and platelet transfusion with serotonin level during living donor liver transplantation: possible connection to graft regeneration. Transplant Proc. 2018; 50:1104–7.

16. de Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Hendriks HG, Slooff MJ, et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg. 2008; 106:32–44.

17. Pereboom IT, de Boer MT, Haagsma EB, Hendriks HG, Lisman T, Porte RJ. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg. 2009; 108:1083–91.

18. Parker BM, Irefin SA, Sabharwal V, Tetzlaff JE, Beven C, Younossi Z, et al. Leukocyte reduction during orthotopic liver transplantation and postoperative outcome: a pilot study. J Clin Anesth. 2004; 16:18–24.

19. Jiwaji Z, Nunn KP, Conway-Morris A, Simpson AJ, Wyncoll D, Rossi AG, et al. RELIEVE Trial Investigators. Leukoreduced blood transfusion does not increase circulating soluble markers of inflammation: a randomized controlled trial. Transfusion. 2014; 54:2404–11.

20. Xia VW, Steadman RH. Antifibrinolytics in orthotopic liver transplantation: current status and controversies. Liver Transpl. 2005; 11:10–8.

21. Alkozai EM, Nijsten MW, de Jong KP, de Boer MT, Peeters PM, Slooff MJ, et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg. 2010; 251:300–6.

22. Matsuo R, Nakano Y, Ohkohchi N. Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann Surg. 2011; 253:759–63.

23. Meyer J, Lejmi E, Fontana P, Morel P, Gonelle-Gispert C, Bühler L. A focus on the role of platelets in liver regeneration: do platelet-endothelial cell interactions initiate the regenerative process? J Hepatol. 2015; 63:1263–71.

24. Starlinger P, Assinger A, Haegele S, Wanek D, Zikeli S, Schauer D, et al. Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans. Hepatology. 2014; 60:257–66.

25. Kema IP, de Vries EG, Muskiet FA. Clinical chemistry of serotonin and metabolites. J Chromatogr B Biomed Sci Appl. 2000; 747:33–48.

26. Stroncek DF, Rebulla P. Platelet transfusions. Lancet. 2007; 370:427–38.

27. Buergy D, Wenz F, Groden C, Brockmann MA. Tumor-platelet interaction in solid tumors. Int J Cancer. 2012; 130:2747–60.

28. Carr BI, Guerra V, Pancoska P. Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma. Oncology. 2012; 83:339–45.

29. Lee CH, Lin YJ, Lin CC, Yen CL, Shen CH, Chang CJ, et al. Pretreatment platelet count early predicts extrahepatic metastasis of human hepatoma. Liver Int. 2015; 35:2327–36.

30. Bambace NM, Holmes CE. The platelet contribution to cancer progression. J Thromb Haemost. 2011; 9:237–49.

31. Labelle M, Hynes RO. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. 2012; 2:1091–9.

32. Sitia G, Aiolfi R, Di Lucia P, Mainetti M, Fiocchi A, Mingozzi F, et al. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci U S A. 2012; 109:E2165–72.

33. Han S, Lee S, Yang JD, Leise MD, Ahn JH, Kim S, et al. Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation. Liver Transpl. 2018; 24:44–55.

34. Parisi I, Tsochatzis E, Wijewantha H, Rodríguez-Perálvarez M, De Luca L, Manousou P, et al. Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria. Liver Transpl. 2014; 20:1327–35.

35. Mousa SA, Petersen LJ. Anti-cancer properties of low-molecular-weight heparin: preclinical evidence. Thromb Haemost. 2009; 102:258–67.

36. Okada H, Honda M, Campbell JS, Sakai Y, Yamashita T, Takebuchi Y, et al. Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development. Cancer Res. 2012; 72:4459–71.

37. Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A; OLT for HCC Consensus Group. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012; 13:e11–22.

38. Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M, et al. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells. Hepatology. 2002; 35:1117–24.

39. Hossain MA, Kim DH, Jang JY, Kang YJ, Yoon JH, Moon JO, et al. Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model. Int J Oncol. 2012; 40:1298–304.

40. Westerkamp AC, Lisman T, Porte RJ. How to minimize blood loss during liver surgery in patients with cirrhosis. HPB (Oxford). 2009; 11:453–8.

41. Zhang T, Sun HC, Xu Y, Zhang KZ, Wang L, Qin LX, et al. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential. Clin Cancer Res. 2005; 11(24 Pt 1):8557–63.

42. Carr BI, Cavallini A, D'Alessandro R, Refolo MG, Lippolis C, Mazzocca A, et al. Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro. BMC Cancer. 2014; 14:43.

43. Morimoto Y, Nouso K, Wada N, Takeuchi Y, Kinugasa H, Miyahara K, et al. Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma. Hepatol Res. 2014; 44:E353–9.

44. Dhanasekaran R, Venkatesh SK, Torbenson MS, Roberts LR. Clinical implications of basic research in hepatocellular carcinoma. J Hepatol. 2016; 64:736–45.

45. Peck-Radosavljevic M, Wichlas M, Zacherl J, Stiegler G, Stohlawetz P, Fuchsjäger M, et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood. 2000; 95:795–801.

46. Pradella P, Bonetto S, Turchetto S, Uxa L, Comar C, Zorat F, et al. Platelet production and destruction in liver cirrhosis. J Hepatol. 2011; 54:894–900.

47. Han S, Lee JH, Kim G, Ko JS, Choi SJ, Kwon JH, et al. Bioreactance is not interchangeable with thermodilution for measuring cardiac output during adult liver transplantation. PLoS One. 2015; 10:e0127981.

48. Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012; 366:610–8.